A central problem in the study of the pathogenesis of liver fibrosis (fibrogenesis) is the identification of the cellular sources of the extracellular matrix and the dissection of the molecular mediators stimulating connective tissue synthesis in certain hepatic target cells. In the present study the role of platelets and of some platelet-derived polypeptide growth factors in the proliferation and proteoglycan synthesis of rat liver fat storing cells in culture (the principle connective tissue-producing cell type in liver) was determined. Fat storing cell proliferation was determined by measurement of the DNA-content, and [ Human platelet lysate (0.3 to 2.6 g protein per litre medium) stimulated, in a dose-dependent manner, both the proliferation and glycosaminoglycan synthesis of rat liver fat storing cells kept äs a primary culture in Dulbecco's modificätion of Eagle's medium in the absence of foetal calf serum. More than 70% of the newly synthesized glycosaminoglycans were found in the medium. Among the various thrombocyte-derived polypeptides tested äs candidate mediators of the platelet-derived fibrogenic activity, platelet derived growth factor was not effective in enhancing glycosaminoglycan synthesis, and it stimulated the proliferation of fat storing .cells only about 2 fold. On the other hand, epidermal growth factor proved to be a Stimulus of both processes. Transforming growth factor (> 10 pmol/1) inhibited foetal calf serum (Dulbecco's modificätion of Eagle's medium with a fraction of foetal calf serum of 0.1) and epidermal growth factor stimulated proliferation but enhanced the synthesis of sulphated glycosaminoglycans about 2-fold. These results suggest the possible role of transforming growth factor äs a negative modulator for fat storing cells proliferation but a positive modulator for fat storing cell transformation and extracellular glycosaminoglycan matrix synthesis. Furthermore, our results indicate a cpoperation between different hepatic and extrahepatic cell types by paracrine Stimulation of fat storing cells. Transfonning growth factor in combination with epidermal growth factor appear to be candidate mediators of the platelet-derived fibrogenic activity, which stimulates fat storing cells in culture, and might also be effective in vivo during hepatic repair processes following liver injury.
Introduction
Persistent liver cell injury, irrespective of its aetiology, (ii) a molecular rearrangement of connective tissue may be follpwed by liver fibrosiSj which is defined by composition, and (i) an excess and irregulär deposition öf connective (iii) modifications of the fine structure of the various tissue elements in the intercellular space, connective tissue molecules (1) .
The main components of human and animal liver extracellular matrix are several types of collagens (2 -5) , some structural glycoproteins (fibronectin, laminin) (6), a group of proteoglycans (proteoheparan sulphate, proteochondroitin sulphate, proteodefmatan (sulphate) (l, 7-9), the glycosaminoglycan, hyaluronic acid (7, 10) , and elastin. In fibrotic liver the concentration of all extracellular matrix elements, except heparan sulphate, is elevated several-fold. The cells responsible for producing the various connective tissue components are hepatocytes, which synthesize predominantly heparan sulphate, äs well äs fibronectin, laminin (6) and potentially some collagens (2, 3) and certain non-parenchymal liver cells (fat storing cells, endothelial cells), which produce several extracellular matrix components. Liver fat storing cells attract increasing interest, because under certain conditions fat storing cells proliferate strongly (4, 9, 11, 12) and transform into myofibroblast like cells (13) . These stain positively for the cytoskeletal protein, desmin (14) , and they produce significant quantities of connective tissue components and, interestingly, a pattern of glycosaminoglycans and collagen similar to that found in fibrotic liver extracellular matrix (l, 4, 5, 7, 8, 15, 16) . These reactions are considered to be important events in human and animal liver fibrogenesis (l, 5, 7, 10, [16] [17] [18] . So far, little is known about the factors (fibrogenic mediators) which promote proliferation/transformation and extracellular matrix synthesis of fat storing cells. Recently, studies from others and from our laboratory have shown that secretions of activated Kupffer cells and monocytes stimulated the proliferation/transformation of fat storing cells in culture (9, 12) , äs well äs stimulating the synthesis of proteoglycans (16) and hyalurönic acid (10) by these cells. Activated macrophages produce platelet derived growth factor, transforming growth factor (19) and transforming growth factor ß, all of which may be candidate mediators of macrophage-derived fibrogenic actitiviy. The findings that (i) an enhanced pool of platelets together with infiltrated inflammatory cells are seen by electron microscopy in liver cell necrotic areas (20) ,
(ii) platelets are the riebest source of transforming growth factor ßl (21, 22) , and (iii) platelet derived growth factor and the transforming growth factor ot-like epidermal growth factor may be released from alpha granules of platelets following platelet activation (23) , support the hypothesis that thrombocytes might be involved in liver fibrogenesis by stimulating the growth, transformation and extracellular matrix synthesis of fat storing cells.
The purpose of this study was to isolate and cultivate rat liver fat storing cells, in order to study the stimulatory potency of human thrombocyte lysate and of platelet derived growth factor, epidermäl growth factor and transforming growth factor on fat storing cell proliferation/transformation and on glycosaminoglycan synthesis. Our results indicate that • t (i) thrombocytes stimulate fat storing cell prölifera-tion and the synthesis and secretion of sulphated glycosaminoglycans by these cells, (ii) transforming growth factor and epidermal growth factor are probably effector molecules of platelet-derived fibrogenic activity. 
Materials and Methods

Materials
Cell isolation and cell culture
Detailed procedures for the Isolation and culture of fat storing cells from rats have been published previously from this labör atory (7^9, 16). Briefly, the cells were isolated from one year old, 500 -650 g male Sprague Dawley rats (Lippische Versuchs·? tierzucht, Extertal, FRG). Non-parenchymal cells were isolated by the pronase/collagenase method of de Leeuw et al. (4), äs originally described by Knook et al. (24) , with some minor modifications described in detail elsewhere (8) . They were puil·· fied by a single-step Nycodenz density gradient (82 g/l). The cells were seeded at a density of 0.2-0. 3 epidermal growth factor (5 -50 μg/l), and transforming growth factor β (0.025-6 μg/l)] were added. Twenty four hours later, the medium was changed in order to introduce radiolabelled precursors, and this new medium also contained fresh Supplements of growth factors.
Determination of cell proliferatipn
DNA measurement
The DNA content of the fat storing cell monolayer (4 days after seeding) was measured fluorometrically using calf thymus DNA (type I, Sigma Chem. Co., Munich, FRG) s a Standard (25) .
[ 3 H]Thymidine incorporation
Thymidine incorporation was measured after trichloroacetic acid precipitation of cells, which had been exposed for 24 h to [ 740 MBq/1 medium) during a labelling period of 24 h [details described elsewhere (7, 8, 16) ]. Usually, the radionuclide was added after a medium change on the 3rd day of primary cuiture. Cultures were stopped by removing the medium, washing the cell layer three times with phosphate buffered saline and freezing the cells. The cells were detached from the well by repeated (3 χ ) freezing and thawing and scraped off with a pipette tip. Less than l % of the radioactivity remained in the well. Details of the procedure to detennine the synthesis and secretion of sulphated glycosaminoglycans are described elsewhere (8) . Briefly, glycosaminoglycans were isolated by binding to DEAESephacel (Pharmacia Fine Chemicals, Uppsala, Sweden), equilibrated with 0.3 mol/1 sodium acetate buffer (pH 6.6), extensively washed with the same buffer, and thereafter eluted with 2.2 mol/1 NaQ. An aliquot of the eluate was mixed with Instagel (Packard Instruments Company, D wners Grove, 111., USA) and c unted for radioactivity. Glycosaminoglycan synthesis was expressed s radioactivity per mg DNA. In experiments using thrombocyte lysate to stimulate fat storing cells, glycosaminoglycans were measured separately in the medium and cell-layer of the cultures. Glycosaminoglycans of the cell layer were determined aftef proteolysis with papain (EC 3.4.22.2) s described previously (8) . 
Results
Fat storing cell proliferation
Effect of thrombocyte lysate
Bromodeoxyuridine incorporation
To study BrdUrd incorporation, fat storing cells were seeded at a density of 0.04-0.1 χ l O 6 cells/cm 2 in Dulbecco's modification of Eagle's medium containing a fraction of 0.1 foetal calf serum on l cm 2 glass cover slips in 6 well (3 ml/well) macroplates (Greiner, N rtingen, FRG). Twenty four h after seeding, foetal calf serum was decreased to 5 ml/1 medium, and growth factors were added. Eighteen h before the end of the culture, BrdUrd (50 μιηοΐ/ΐ final concentration) was added. At the end of the culture period, monolayers were washed twice with phosphate buffered saline-Dw/fecco's modification of Eagle's medium (pH 7.4) and fixed with ethanol/acetic acid 95-1-5 (by vol.). DNA was then denatured by incubating the cells for 45 min at 37 °C with BrdUrd antibodies and nuclease. After washing 3 times with phosphate buffered saline (pH 7.4) cells were incubated with peroxidase-conjugated rabbit anti-mouseimmunoglobulins for 45 min at 37 °C. Cells were then washed again 3 times with phosphate buffered saune, and the nuclei, which had taken up BrdUrd, were stained with 3,3'-diaminobenzidine tetrahydrochloride s Substrate and hydrogen peroxide 3%, nickel Chloride and cobalt chloride 30 g/l in H 2 O s intensifier.
Determination of the synthesis of total glycosaminoglycans . 3b ). In the presence of a higher foetal calf serum concentration (100 ml/l), epidermal growth factor failed to stimulate fat storing cell proliferation further (data not shown). This book is a comprehensive and up-todate review ön the importance of selenium in human and animal nutrition. Starting from physiological aspects, it covers epidemiological and clinical data, giving detailed Information on selenium requirementSj supplementation and toxicity, and the methods for assessing selenium Status. It includes contributions from famous experts and specialists in the field. the culture period was only 4 days, the Inhibition of [ 3 H]lhymidine incorporation was more pronounced (significant reduction with 10 pmol/1 transfonning growth factor ß) than the decrease of the DNA content (significant reduction with 100 pmol/1 transfonning growth factor ). higher transforming growth factor concentration (6 g/l, 240 pmol/1), added on second and third day after seeding to primary cultures of rat fat storing cells (containing 0.005 foetal calf serum) inhibited basal [ 3 H]thymidine incorporation by 90%, while epidermal growth factor (50 g/l, 9.1 nmol/1) stimulated cell proliferation by 92% (flg. 5). In a further experiment, fat storing cells were seeded at a density of 3000 cells/cm 2 and grown in Dulbecco's modification of Eagle's medium containing a fraction of 0.1 foetal calf serum in the presence or absence of 20 pmol/1 transforming growth factor ß. Cultures were stopped after 2, 6, 8, 14, 16 and 18 days. Total cell numbers were counted using phase-contrast microscopy, and the fraction of desmin-positive cells was counted after immunoperoxidase staining for desmin. While inhibitijig cell growth, transforming growth factor ß stimulated fat storing cell transformation to desmin-positive myofibroblast-like cells ( fig. 6 ).
Platelet derived growth factor-stimulated fat storing cell proliferation
Platelet derived growth factor (0.5 §/1, 16.6 pmol/1) was added, on the 2nd day after seeding to primary cultures of fat storing cells grown in Dulbecco's modification of Eagle's medium without foetal calf serum. Under these conditions, platelet derived growth factor stimulated fat storing cells proliferation, äs measured by [ 3 H]thymidine incorporation, to a maximum of 2.1-fold compared with controls (tab. 2). The DNA content was increased by platelet derived growth factor (2 g/l, 66 pmol/1) during 48 h of Stimulation to 1.24fold ofcontrol.
Synthesis and secretion of glycosaminoglycans by rat liver fat storing cells
Stimulation by thrombocyte lysate
Thrombocyte lysate caused a dose-dependent increase (up to 8-fold) of the incorporation of [ becco's modification of Eagle's medium containing a fraction of 0.1 foetal calf serum, the stimulatory effect of thrombocyte lysate on proteoglycan synthesis was much weaker (only 2-fold), suggesting that the enhancement of proteoglycan synthesis by foetal calf serum is largely due to platelet derived factors.
Epidermal growth factor-stimulatedglycosaminoglycan synthesis
In the presence of 5 ml/l foetal calf serum, epidermal growth factor significantly stimulated proteoglycan synthesis, s measured by [ 
Transforming growth factor -stimulated glycosaminoglycan synthesis
Treatment of fat storing cells with transforming growth factor β caused a dose-dependent enhanced radiosulphate incorporation into secreted (medium) glycosaminoglycans, with a maximal increase of about 2-fold at 2.5 μg/l in Dulbecco's modification ofEagle's medium containing 5 ml/l foetal calf serum ( fig. 8a ) and a maximal increase of about 1.7 fold at l μg transforming growth factor β per litre Dulbecco's modification of Eagle's medium containing 100 ml/l foetal calf serum ( fig. 8b) . In a preliminary experiment we found that in controls (Dulbecco's modification of Eagle's medium containing a fraction of 0.005 foetal calf serum) most (75%) of the incorporated [ phate. Addition of transforming growth factor β reduced the relative radiosulphate content of dermatansulphate from 75% to 62%, and of heparan-sulphate from 20 to 10%, but increased the relative [ 35 S]sulphate content of chondroitin-sulphate from 5 to 32%. In contrast to newly synthesized and secreted dermatan-sulphate and heparan-sulphate, the absolute [ 35 S]sulphate incorporation, expressed s radiosulphate incorporation per mg DNA into chondroitin-sulphate, was also significantly stimulated by transforming growth factor β (at 0.5 μg/l about 7-fold and at 2.0 μg/l more than 8-fold) compared with controls.
Effecl ofplatelet derived growth factor on glycosaminoglycan synthesis
Platelet derived growth factor (0.25 -5.0 μ §/1, 8.3 -166 pmol/1), added on the 2nd day after seeding to primary cultures of fat storing cells grown in Dulbec*· co*s modification of Eagle's medium without or with a fraction of 0.1 foetal calf serum, did not significantly increase the quantity of glycosaminoglycan synthesised per mg DNA.
Discussion
The ability of liver fat storing cells to proliferate strongly (9, 11, 12) , and to transform into myofibroblast-like cells (4, 11, 13) which produce significant quantities of connective tissue components, is considered to be an important event in human and animal ver fibrogenesis (l, 5, 7, 10, 16, 17, 18) . Following all types of hepatic injury, an Infiltration of the tissue with blood monocytes occurs, and this is paralleled by an enhanced proliferation of Kupffer cells (26) followed by a stimulated proliferation and transformation of fat storing cells. These observations and the electron microscopic demonstration of platelets together with infiltrated inflammatory cells in liver cell necrotic areas (20) support the hypothesis that factors released from these cells might directly promote the growth, transformation and extracellular matrix synthesis of fat storing cells.
Studies from others and from our laboratory support this hypothesis. It was shown recently that secretions of activated Kupffer cells and monocytes stimulate the proliferation/transformation of fat storing cells in culture (9, 12), s well s the synthesis of proteoglycans (16) and hyaluronic acid (10) by these cells. Comparing the magnitude of matrix proteoglycan and hyaluronate synthesis by fat storing cells with that of other liver cells, it was concluded that the fat storing cell is the most important cell in liver fibrogenesis (7) . In cultures of fat storing cells labelled for 24h with (7), At present, the function of the s lphated glycosaminogiycans and other matrix elements seereted by fat storing cells is poorly understood. Several authors propose that the interaction of cells with the extracellular matfix influences cell behaviour, affecting cell adhesion and motility, growth and differentiation (for review see 1. c. (27) ). Important new aspects of the putative functions of glycosaminogiycans are pr vided by observations showing that type ΪΪΙ transforming growth factor β receptor is a membrane heparan/chondroitin sulphate proteoglycan (28, 29) and that certain glycosaminogiycans act s reservoirs of growth factors (30) . However, we have so far been unable to relate the high Output of glycosaminogiycans by fat storing cells to specific autocrine or paracrine effects.
In the present study we demonstrated for the first time that platelets contain fibrogenic mediators which stimulate not only proliferation, b t also the synthesis and secretion of glycosaminogiycans into the extracellular matrix by fat storing cells in primary culture. The main growth factors elaborated by platelets are transforming growth factor β (platelets are the riebest source of transforming growth factor l (21)), platelet derived growth factor (31) and epidermal growth factor (23) . The data presented in this study clearly demonstrate that primary cultures of rat fat storing cells grown in Dulbecco's modification of Eagle's medium containing a fraction of 0.005 foetal calf serum show a mitogenic response to human epidermal growth factor and platelet derived growth factor. Recently, we demonstrated that the epidermal growth factor-like transforming growth factor a, which is produced by activated macrophages (19) and probably Kupffer cells (Bachern, unpublished data), binds to epidermal growth factor receptor on fat storing cells with a similar affinity to that of epidermal growth factor, and stimulates the proliferation of fat storing cells in culture (32) . Epidermal growth factor and transforming growth factor α are equally potent in the Stimulation of fat storing cell proliferation.
Transforming growth factor , a M T = 25 000 disulphide-linked homodimer originally found in transformed fibroblasts (21, 22) bel ngs to a family of growth factors that regulate cell growth and differentiation (for review see I.e. (33) ). Transforming growth factor β has been found to be both stimulator (33, 34) and an inhibitor of cell growth (28, (33) (34) (35) (36) (37) depending on the System studied. We showed that transforming growth factor β strongly irihibited the proliferation of fat storing cells stimulated by foetal calf serum or epidermal growth factor. Similar results, i.e. a dose-dependent Inhibition of the epidermal growth factor-stimulated proliferation, were obtained with cultured rat aortic smooth muscle cells (37) . As proposed by Sporn et al. (38) and Roberts et al. (34) transforming growth factor β stimulates or inhibits proliferation s a function of the entire set of growth factors present within the cell. Several in vitro studies indicate that transforming growth factor β may control the effects of other polypeptide growth factors, such s platelet derived growth factor, epidermal growth factor/transforming growth factor a, basic fibroblast growth factor and interleukin 2, and that transforming growth factor β can determine whether a cell responds in a positive or negative manner to such a growth factor (for review see 1. c. (38) ). This action of transforming growth factor β seems to be exerted via modulation of growth factor receptors, since it was shown recently that transforming growth factor β inhibits epidermal growth factor/transforming growth factor α binding to the high affinity epidermal growth factor cell surface receptors on fibroblasts (39) , and furthermore that the platelet derived growth factor-stimulated proliferation of bone marrow fibroblasts is also inhibited by interaction of transforming growth factor β with platelet derived growth factor binding (35) .
In cultured normal human dermal fibroblasts transforming growth factor β stimulates the synthesis of types I and III collagens (40, 41) and fibronectin (40, 41, 42) . In endothelial cells, fibronectin synthesis is also stimulated by transforming growth factor β (36). It is suggested that transforming growth factor β may play a role in the normal regulation of extracell lar matrix production in vivo, and may contribute to the development of pathologic l states of skin (41) and organ (43) fibrosis. The observation by Wiseman and coworkers (44) , that transforming growth factor β at Very low concentrations (16-100 ng/1) may recruit monocytes from the circulation and activate them to express factors like tumour necrosis factor a, may also by very relevant to fibrogenesis. Transforming growth factor β stimulates Collagen synthesis in fat storing cells (45) . We show here for the first time that transforming growth factor β added to primary cultures of fat storing cells stimulates glycosaminoglycan synthesis and extracell lar deposition of glycosaminoglycans. In bovine cartilage organ cultures, transforming growth factor β was also shown to regulate the metabolism of glycosaminoglycans (46). Preliminary results showing that the synthesis of chondroitin sulphate is preferentially stimulated by transforming growth factor β agree with observations made by others in mouse mammary epithelial cells (27) .
Our results demonstrate that thrombocytes release fibrogenic mediators which stimulate fat storing cell proliferation/transformation and glycosaminoglycan synthesis by these cells. All three polypeptide growth factors studied (epidermal growth factor, platelet derived growth factor and transforming growth factor ) are candidate mediators of platelet-derived fibrogenic activity in culture, and in vivo during hepatic injury. Others have shown that in acute CC1 4 liver damage the level of transforming growth factor β mRNA rises 24 h later and peaks at 48 h (47) , and that transforming growth factor β gene expression is significantly enhanced during active fibrogenesis associated with liver disease in man (48). Together with these observations, the results presented here indicate a central, fundamental role for transforming growth factor β in hepatic fibrogenesis.
Conclusion
The observation that activated Kupffer cells, monocytes and thrombocytes, whose numbers are increased in areas of liver cell injury, stimulate fat storing cell proliferation/transformation and extracell lar matrix synthesis, indicates the existence of cooperative interactions between different hepatic and extrahepatic cell types, mediated by paracrine mechanisms. These interactions seem to be important in liver fibrogenesis, a process in which transforming growth factor β may play a central role.
